 Progesterone
"Progesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
| Descriptor ID |
D011374
|
| MeSH Number(s) |
D04.210.500.745.745.654.829 D06.472.334.734.623 D06.472.334.851.687.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Progesterone".
Below are MeSH descriptors whose meaning is more specific than "Progesterone".
This graph shows the total number of publications written about "Progesterone" by people in this website by year, and whether "Progesterone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1996 | 0 | 2 | 2 | | 1997 | 4 | 2 | 6 | | 1998 | 4 | 2 | 6 | | 1999 | 1 | 4 | 5 | | 2000 | 3 | 4 | 7 | | 2001 | 1 | 2 | 3 | | 2002 | 2 | 3 | 5 | | 2003 | 2 | 4 | 6 | | 2004 | 2 | 4 | 6 | | 2005 | 3 | 2 | 5 | | 2006 | 2 | 3 | 5 | | 2007 | 4 | 1 | 5 | | 2008 | 2 | 4 | 6 | | 2009 | 1 | 1 | 2 | | 2010 | 4 | 3 | 7 | | 2011 | 5 | 3 | 8 | | 2012 | 1 | 3 | 4 | | 2013 | 2 | 1 | 3 | | 2014 | 2 | 3 | 5 | | 2015 | 1 | 5 | 6 | | 2016 | 2 | 1 | 3 | | 2017 | 1 | 4 | 5 | | 2018 | 3 | 2 | 5 | | 2019 | 5 | 3 | 8 | | 2020 | 3 | 4 | 7 | | 2021 | 4 | 0 | 4 | | 2022 | 0 | 4 | 4 | | 2023 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Progesterone" by people in Profiles.
-
Miller KN, Standeven L, Morrow AL, Payne JL, Epperson CN, Hantsoo L. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2024 Feb; 160:106684.
-
Kantarci K, Tosakulwong N, Lesnick TG, Kara F, Kendall-Thomas J, Kapoor E, Fields JA, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial. Menopause. 2024 Jan 01; 31(1):10-17.
-
Plewes MR, Talbott HA, Saviola AJ, Woods NT, Schott MB, Davis JS. Luteal Lipid Droplets: A Novel Platform for Steroid Synthesis. Endocrinology. 2023 08 01; 164(9).
-
Heyborne K. Reassessing Preterm Birth Prevention After the Withdrawal of 17-a Hydroxyprogesterone Caproate. Obstet Gynecol. 2023 09 01; 142(3):493-501.
-
Fuller KNZ, McCoin CS, Stierwalt H, Allen J, Gandhi S, Perry CGR, Jambal P, Shankar K, Thyfault JP. Oral combined contraceptives induce liver mitochondrial reactive oxygen species and whole-body metabolic adaptations in female mice. J Physiol. 2022 12; 600(24):5215-5245.
-
Novick AM, Duffy KA, Johnson RL, Sammel MD, Cao W, Strasser AA, Sofuoglu M, Kuzma A, Loughead J, Epperson CN. Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence. Nicotine Tob Res. 2022 11 12; 24(12):1898-1905.
-
Novick AM, Duffy KA, Johnson RL, Sammel MD, Cao W, Strasser AA, Sofuoglu M, Kuzma A, Loughead J, Morrow AL, Epperson CN. Effect of progesterone administration in male and female smokers on nicotine withdrawal and neural response to smoking cues: role of progesterone conversion to allopregnanolone. Biol Sex Differ. 2022 10 23; 13(1):60.
-
Liang J, Ingalla ER, Yao X, Wang BE, Tai L, Giltnane J, Liang Y, Daemen A, Moore HM, Aimi J, Chang CW, Gates MR, Eng-Wong J, Tam L, Bacarro N, Roose-Girma M, Bellet M, Hafner M, Metcalfe C. Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer. Sci Transl Med. 2022 09 21; 14(663):eabo5959.
-
Clark ZL, Ruebel ML, Schall PZ, Karl KR, Ireland JJ, Latham KE. Follicular Hyperstimulation Dysgenesis: New Explanation for Adverse Effects of Excessive FSH in Ovarian Stimulation. Endocrinology. 2022 09 01; 163(9).
-
Clark ZL, Karl KR, Ruebel ML, Latham KE, Ireland JJ. Excessive follicle-stimulating hormone during ovarian stimulation of cattle may induce premature luteinization of most ovulatory-size follicles?. Biol Reprod. 2022 05 17; 106(5):968-978.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|